Bayer Leads Investment in U.S. Oncology Startup
July 17 2019 - 9:40AM
Dow Jones News
By Kim Richters
Germany's Bayer AG (BAYN.XE) said Wednesday that it has led a
financing round in a U.S. startup researching potential cancer
treatments.
The German conglomerate, which is battling legal cases in the
U.S. tying its Roundup weedkiller to cancer, said it had invested
$11 million in startup Pyxis Oncology via its investment arm Leaps
by Bayer. Investors Agent Capital, Ipsen and Longwood Fund also
contributed another $11 million, according to Bayer.
The newly founded Pyxis aims to develop antibody-based
immunotherapies for cancer patients.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
July 17, 2019 09:25 ET (13:25 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Bayer (TG:BAYN)
Historical Stock Chart
From Oct 2023 to Oct 2024